NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations

Table 1 Distribution of seven polymorphisms in the NAT2 gene among 100 gastric cancer patients and 100 controls, and cancer risk predisposition

	G191A		C282T		T341C		C481T		G590A		A803G		G857A
	Con	C	Con	C	Con	C	Co	C	Co	C	Co	C	Co	C
Frequency	0.0	0.0	0.39	0.35	0.36	0.44	0.31	0.41	0.35	0.29	0.39	0.52	0.09	0.05
W/W	100	76	46	43	42	29	49	35	42	49	39	17	83	87
W/M	0	0	30	44	44	53	39	47	46	44	44	60	17	10
MM	0	0	24	13	14	18	12	18	12	7	17	22	0	1
P	NS		0.8		0.08		0.06		0.4		0.001		0.6
OR	-		1.1		1.3		1.8		0.7		3.1		0.7
(95% CI)			(0.6-2.1)		(0.9-1.7)		(0.9-3.3)		(0.4-1.4)		(1.5-6.3)		(0.3-1.7)
M carrier